Related Experiment Video
Updated: May 5, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
The Memory Assessment Scale: A Population-based Cognitive Impairment Screening Instrument
William T Tsushima1, Justin R Abe2, Andrea M Siu3
1Straub Medical Center, Honolulu, HI (WTT).
Hawai'I Journal of Health & Social Welfare
|March 8, 2024
Summary
The Memory Assessment Scale (MAS) may not effectively screen for mild cognitive impairment in Hawai'i. Further research is needed to determine its validity and reliability as a cognitive screening tool in this population.
Area of Science:
- Neuroscience
- Psychology
- Gerontology
Background:
- The Memory Assessment Scale (MAS) was developed in Hawai'i in 1987.
- Cognitive impairment screening is crucial for early detection and intervention.
- The continued validity and reliability of the MAS in Hawai'i needed re-examination.
Purpose of the Study:
- To re-evaluate the Memory Assessment Scale (MAS) as a cognitive impairment screening tool.
- To determine if the MAS remains valid and reliable for use in Hawai'i.
- To assess the MAS's ability to differentiate between individuals with and without mild cognitive impairment.
Main Methods:
- Patients with suspected neurocognitive dysfunction were assessed.
- Participants were categorized into two groups: mild cognitive impairment and no mild cognitive impairment.
- Classification was based on comprehensive neuropsychological testing.
Main Results:
- No significant differences in Memory Assessment Scale (MAS) scores were observed between the mild cognitive impairment group and the control group.
- The MAS did not differentiate between patients with and without mild cognitive impairment in this study.
Conclusions:
- The Memory Assessment Scale (MAS) may not be a suitable screening tool for mild cognitive impairment in Hawai'i.
- Further research is recommended to validate the MAS.
- Comparative studies of the MAS with healthy controls are indicated to assess its efficacy.

